The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Pentasa 500 mg prolonged-release tablets



PCO Manufacturing Ltd.PPA0465/450/002

Main Information

Trade NamePentasa 500 mg prolonged-release tablets
Active SubstancesMesalazine
Dosage FormProlonged-release tablet
Licence HolderPCO Manufacturing Ltd.
Licence NumberPPA0465/450/002

Group Information

ATC CodeA07EC02 mesalazine

Status

License statusAuthorised
Licence Issued22/05/2020
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back